Aclarion Inc (ACON)vsTempus AI, Inc. Class A Common Stock (TEM)
ACON
Aclarion Inc
$1.74
-1.14%
HEALTHCARE · Cap: $5.62M
TEM
Tempus AI, Inc. Class A Common Stock
$77.80
-0.87%
HEALTHCARE · Cap: $12.32B
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 1709365% more annual revenue ($1.43B vs $83,770). ACON leads profitability with a 0.0% profit margin vs -17.8%. ACON earns a higher WallStSmart Score of 33/100 (F).
ACON
Avoid33
out of 100
Grade: F
TEM
Avoid28
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 30.5% year-over-year
Revenue surging 21.6% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
0.0% earnings growth
Trading at 31.5x book value
ROE of -57.2% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : ACON
The strongest argument for ACON centers on Price/Book, Revenue Growth. Revenue growth of 30.5% demonstrates continued momentum.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum.
Bear Case : ACON
The primary concerns for ACON are EPS Growth, Market Cap, Profit Margin.
Bear Case : TEM
The primary concerns for TEM are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 3.25 is elevated, increasing financial risk.
Key Dynamics to Monitor
ACON profiles as a hypergrowth stock while TEM is a growth play — different risk/reward profiles.
TEM carries more volatility with a beta of 3.54 — expect wider price swings.
ACON is growing revenue faster at 30.5% — sustainability is the question.
ACON generates stronger free cash flow (-3M), providing more financial flexibility.
Bottom Line
ACON scores higher overall (33/100 vs 28/100) and 30.5% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aclarion Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Aclarion Inc (ACON) is an innovative healthcare technology company focused on transforming the diagnosis and management of musculoskeletal conditions through advanced non-invasive imaging and data analytics. Leveraging machine learning capabilities, Aclarion provides healthcare professionals with actionable insights that improve clinical outcomes while optimizing cost-effective treatment pathways. As a key player in the digital health arena, the company is positioned to address the growing demand for effective diagnostic solutions, thereby enhancing patient care and management in a rapidly evolving healthcare environment. Aclarion's commitment to improving patient outcomes places it at the forefront of future healthcare delivery advancements.
Visit Website →Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?